Labor Analgesia Initiation with Dural Puncture Epidural versus Standard Epidural Techniques: A Prospective Randomized Dose Allocation Study of Ropivacaine.

IF 5.1 2区 医学 Q1 CHEMISTRY, MEDICINAL
Drug Design, Development and Therapy Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI:10.2147/DDDT.S547879
Fei Xiao, Dan M Drzymalski, Yu-Fang Dong, Jia-Yue Huang, Yan Gao, Hai-Ya Yan, Hui-Jing Hu
{"title":"Labor Analgesia Initiation with Dural Puncture Epidural versus Standard Epidural Techniques: A Prospective Randomized Dose Allocation Study of Ropivacaine.","authors":"Fei Xiao, Dan M Drzymalski, Yu-Fang Dong, Jia-Yue Huang, Yan Gao, Hai-Ya Yan, Hui-Jing Hu","doi":"10.2147/DDDT.S547879","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>When compared to the standard epidural technique, the dural puncture epidural (DPE) technique is reported to provide quicker onset of labor analgesia and improved quality of analgesia. Recently, the DPE technique was found to lower the effective dose for 90% (ED90) of patients receiving bupivacaine for labor analgesia by 35%. However, key pharmacological differences between bupivacaine and ropivacaine and the effect of a DPE technique on ropivacaine doses have not been studied. Therefore, we aimed to determine the effective dose for 50% (ED50) and ED90 of ropivacaine for labor analgesia in parturients when initiated with the DPE and standard epidural techniques.</p><p><strong>Methods: </strong>Study participants were randomized to receive one of the five doses of ropivacaine (12, 15, 18, 21, and 24 mg) undergoing one of the two epidural techniques (either a DPE or standard epidural technique). A total volume of 20 mL of local anesthetic was administered epidurally. Effective analgesia was defined as the patient reporting an NRS pain score < 3 at 20 minutes following drug administration. The ED50 and ED90 values of epidural ropivacaine for labor analgesia were determined using probit analysis, and comparisons were made using the relative median potency ratio.</p><p><strong>Results: </strong>The ED50 of ropivacaine for initiating labor analgesia using the DPE vs standard epidural techniques was 18.6 mg (95% CI, 16.4 to 21.1 mg) vs 19.2 mg (95% CI, 17.0 to 21.8 mg), respectively. The ED90 values were 30.5 mg (95% CI, 26.6 to 38.3 mg) vs 31.1 mg (95% CI, 27.1 to 39.2 mg), respectively. The relative median potency ratio for ropivacaine with DPE vs standard epidural technique was -0.6 (95% CI, -4.0 to 2.6).</p><p><strong>Conclusion: </strong>Our findings suggest that there is no dose-sparing effect of ropivacaine when using the DPE technique vs a standard epidural technique for labor analgesia.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"8745-8753"},"PeriodicalIF":5.1000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S547879","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: When compared to the standard epidural technique, the dural puncture epidural (DPE) technique is reported to provide quicker onset of labor analgesia and improved quality of analgesia. Recently, the DPE technique was found to lower the effective dose for 90% (ED90) of patients receiving bupivacaine for labor analgesia by 35%. However, key pharmacological differences between bupivacaine and ropivacaine and the effect of a DPE technique on ropivacaine doses have not been studied. Therefore, we aimed to determine the effective dose for 50% (ED50) and ED90 of ropivacaine for labor analgesia in parturients when initiated with the DPE and standard epidural techniques.

Methods: Study participants were randomized to receive one of the five doses of ropivacaine (12, 15, 18, 21, and 24 mg) undergoing one of the two epidural techniques (either a DPE or standard epidural technique). A total volume of 20 mL of local anesthetic was administered epidurally. Effective analgesia was defined as the patient reporting an NRS pain score < 3 at 20 minutes following drug administration. The ED50 and ED90 values of epidural ropivacaine for labor analgesia were determined using probit analysis, and comparisons were made using the relative median potency ratio.

Results: The ED50 of ropivacaine for initiating labor analgesia using the DPE vs standard epidural techniques was 18.6 mg (95% CI, 16.4 to 21.1 mg) vs 19.2 mg (95% CI, 17.0 to 21.8 mg), respectively. The ED90 values were 30.5 mg (95% CI, 26.6 to 38.3 mg) vs 31.1 mg (95% CI, 27.1 to 39.2 mg), respectively. The relative median potency ratio for ropivacaine with DPE vs standard epidural technique was -0.6 (95% CI, -4.0 to 2.6).

Conclusion: Our findings suggest that there is no dose-sparing effect of ropivacaine when using the DPE technique vs a standard epidural technique for labor analgesia.

硬脊膜外穿刺与标准硬脊膜外技术的分娩镇痛起始:罗哌卡因的前瞻性随机剂量分配研究。
背景:与标准硬膜外技术相比,硬膜穿刺硬膜外(DPE)技术可提供更快的分娩镇痛,并改善镇痛质量。最近,DPE技术被发现可以将90%的布比卡因分娩镇痛患者的有效剂量(ED90)降低35%。然而,布比卡因和罗哌卡因之间的主要药理学差异以及DPE技术对罗哌卡因剂量的影响尚未研究。因此,我们的目的是确定在DPE和标准硬膜外技术启动时,罗哌卡因用于分娩镇痛的有效剂量为50% (ED50)和ED90。方法:研究参与者随机接受五种剂量的罗哌卡因(12,15,18,21和24mg),并接受两种硬膜外技术中的一种(DPE或标准硬膜外技术)。在硬膜外注射20ml局麻药。有效镇痛定义为患者在给药后20分钟报告NRS疼痛评分< 3。采用probit分析确定硬膜外罗哌卡因用于分娩镇痛的ED50和ED90值,并采用相对中位效比进行比较。结果:采用DPE与标准硬膜外技术启动分娩镇痛时,罗哌卡因的ED50分别为18.6 mg (95% CI, 16.4 ~ 21.1 mg)和19.2 mg (95% CI, 17.0 ~ 21.8 mg)。ED90值分别为30.5 mg (95% CI, 26.6 ~ 38.3 mg)和31.1 mg (95% CI, 27.1 ~ 39.2 mg)。DPE罗哌卡因与标准硬膜外技术的相对中位效价比为-0.6 (95% CI, -4.0至2.6)。结论:我们的研究结果表明,当使用DPE技术与标准硬膜外技术进行分娩镇痛时,罗哌卡因没有剂量节约效应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Design, Development and Therapy
Drug Design, Development and Therapy CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
CiteScore
9.00
自引率
0.00%
发文量
382
审稿时长
>12 weeks
期刊介绍: Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信